We have read with a great interest the review published by Singh et al, on the treatment options in alcoholic and non-alcoholic fatty liver disease, including v
Hepatitis C virus (HCV) has a high propensity toestablish chronic infections. Failure of HCV-infectedindividuals to activate effective antiviral immuneresponses i